Development of a Cancer Vaccine Targeting Tumor Blood Vessels

作者: Elisabeth J. M Huijbers

DOI:

关键词:

摘要: We have recently shown that immunization against the extra domain-B (ED-B) of fibronectin, using Freund's adjuvant, reduces tumor growth in mice by 70%. In present study we compare immune response generated ED-B non-toxic and biodegradable adjuvant Montanide ISA 720/CpG with elicited adjuvant. induced anti-ED-B antibodies higher avidity less variable levels between individuals than Freund's. Moreover, duration was longer generation naive faster, when used. conclude it is possible to replace mineral oil based an acceptable for human use, which a prerequisite transfer vaccine clinic.

参考文章(390)
Laurence Arbibe, Jean-Paul Mira, Nicole Teusch, Lois Kline, Mausumee Guha, Nigel Mackman, Paul J. Godowski, Richard J. Ulevitch, Ulla G. Knaus, Toll-like receptor 2-mediated NF-kappa B activation requires a Rac1-dependent pathway. Nature Immunology. ,vol. 1, pp. 533- 540 ,(2000) , 10.1038/82797
P. Pujuguet, J. L. Samuel, M. Martin, A. Hammann, M. Moutet, F. Martin, Expression of fibronectin ED-A+ and ED-B+ isoforms by human and experimental colorectal cancer. Contribution of cancer cells and tumor-associated myofibroblasts. American Journal of Pathology. ,vol. 148, pp. 579- 592 ,(1996)
Napoleone Ferrara, None, The role of VEGF in the regulation of physiological and pathological angiogenesis Mechanisms of Angiogenesis. pp. 209- 231 ,(2005) , 10.1007/3-7643-7311-3_15
Carina Hellberg, Arne Östman, C.-H. Heldin, PDGF and Vessel Maturation Recent results in cancer research. ,vol. 180, pp. 103- 114 ,(2010) , 10.1007/978-3-540-78281-0_7
Jürgen Engel, Matthias Chiquet, An Overview of Extracellular Matrix Structure and Function Springer, Berlin, Heidelberg. pp. 1- 39 ,(2011) , 10.1007/978-3-642-16555-9_1
Anne Eichmann, Karine Bouvrée, Luc Pardanaud, Vasculogenesis and Angiogenesis in Development Tumor Angiogenesis. pp. 31- 45 ,(2008) , 10.1007/978-3-540-33177-3_2
Chiquet-Ehrismann R, Tenascin and other adhesion-modulating proteins in cancer. Seminars in Cancer Biology. ,vol. 4, pp. 301- 310 ,(1993)